Microencapsulated stem cells for tissue repairing: Implications in cell-based myocardial therapy

Regenerative Medicine

Volumn 4, Issue 5, 2009, Pages 733-745

  Paul, Arghya ^a   Ge, Yin ^b   Prakash, Satva ^a   Shum Tim, Dominique ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Artificial stem cells; Cellular cardiomyoplasty; Delivery system; Microencapsulation; Microenvironment; Polymers; Regenerative therapy stem cells

Indexed keywords

ALGINATE POLYLYSINE ALGINATE; ALGINIC ACID; BONE MORPHOGENETIC PROTEIN 2; CALCIUM ALGINATE; CHITOSAN; METHACRYLIC ACID DERIVATIVE; POLYMER;

CARDIOMYOPLASTY; CELL DIFFERENTIATION; CELL REGENERATION; CELL SUSPENSION; CELL THERAPY; CELL TRANSPLANTATION; EMBRYONIC STEM CELL; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMORAL IMMUNITY; IMMOBILIZED CELL; IMMUNOGENICITY; MESENCHYMAL STEM CELL; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REPAIR;

ANIMALS; CARDIAC SURGICAL PROCEDURES; CELL CULTURE TECHNIQUES; DRUG COMPOUNDING; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 70350771402     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.43     Document Type: Review

References (91)

1. Hansen LT, Ian-Wojtas PM, Jin YL, Paulson AT: Survival of Ca-alginate microencapsulated Bifidebacterium spp. in milk and simulated gastrointestinal conditions. Food Microbiol. 19(1), 35-45 (2002).
2. Park JK, Chang HN: Microencapsulation of microbial cells. Biotechnol. Adv. 18(4), 303-319 (2000).
3. Orive G, Hernandez RM, Gascon AR, Igartua M, Pedraz JL: Controversies over stem cell research. Trends Biotechnol. 21(3), 109-112 (2003).
4. Chang TMS: Semipermeable microcapsules. Science 146(3643), 524-525 (1964).
5. Hua L, Aoki T, Jin Z et al.: Elevation of serum albumin levels in nagase analbuminemic rats by allogeneic bone marrow cell transplantation. Eur. Surg. Res. 37(2), 111-114 (2005).
6. Sherman W, Martens TP, Gonzalez JF, Siminiak T: Catheter-based delivery of cells to the heart. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1), S57-S64 (2006).
7. Behr L, Hekmati M, Fromont G et al.: Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney. Nephron Physiol. 107(3), 65-76 (2007).
8. Fujii H, Hirose T, Oe S et al.: Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J. Hepatol. 36(5), 653-659 (2002).
9. Arbab AS, Jordan EK, Wilson LB, Yocum GT, Lewis BK, Frank JA: In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum. Gene Ther. 15(4), 351-360 (2004).
10. Liu ZC, Chang TMS: Transdifferentiation of bioencapsulated bone marrow cells into hepatocyte-like cells in the 90% hepatectomized rat model. Liver Transpl. 12(4), 566-572 (2006).
11. + bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 23(4), 463-470 (2005).
12. Dib N, Michler RE, Pagani FD et al.: Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112(12), 1748-1755 (2005).
13. Wollert KC, Meyer GP, Lotz J et al.: Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 364(9429), 141-148 (2004).
14. Thompson CA, Nasseri BA, Makower J et al.: Percutaneous transvenous cellular cardiomyoplasty: a novel nonsurgical approach for myocardial cell transplantation. J. Am. Coll. Cardiol. 41(11), 1964-1971 (2003).
15. Sun ZJ, Lu Gj, Li SY et al.: Differential role of microenvironment in microencapsulation for improved cell tolerance to stress. Appl. Microbiol. Biotechnol. 75(6), 1419-1427 (2007).
16. Orive G, Hernández, RM, Gascón AR, Igartua M, Pedraz JL: Survival of different cell lines in alginate-agarose microcapsules. Eur. J. Pharm. Sci. 18, 23-30 (2003).
17. Prakash S, Chang TMS: Preparation and in vitro analysis of microencapsulated genetically-engineered Escherichia coli dh5 cells for urea and ammonia removal. Biotechnol. Bioeng. 46(6), 621-626 (1995).
18. Christensen L, Dionne KE, Lysaght MJ: Biomedical applications of immobilized cells. In: Fundamentals of Animal Cell Encapsulation and Immobilization. Goosen MFA (Ed.). CRC Press, Boca Raton, FL, USA 7-29 (1993).
19. Chang TMS, Prakash S: Therapeutic uses of microencapsulated genetically engineered cells. Mol. Med. Today 4(5), 221-227 (1998).
20. Orive G, Hernández; RM, Rodríguez Gascón A et al.: History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 22(2), 87-92 (2004).
21. Prakash S, Chang TMS: Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat. Med. 2(8), 883-887 (1996).
22. Prakash S, Chang TMS: Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in vitro and in vivo. Artif Cells Blood Substit. Immobil. Biotechnol. 28(5), 397-408 (2000).
23. Prakash S, Chang TM: Artificial cell microcapsules containing genetically engineered E. coli DH5 cells for in vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: a preliminary report. Artif. Cell Blood Substit. Biotechnol. 27(5-6), 475-481 (1999).
24. Soon-Shiong P, Heintz RE, Merideth N et al.: Insulin independence in a Type 1 diabetic patient after encapsulated islet transplantation. Lancet 343(8903), 950-951 (1994).
25. Calafiore R, Basta G: Artificial pancreas to treat Type 1 diabetes mellitus. Methods Mol. Med. 140, 197-236 (2007).
26. Chang TMS, Prakash S: Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms. Mol. Biotechnol. 17(3), 249-260 (2001).
27. Prakash S, Jones ML: Artificial cell therapy: new strategies for the therapeutic delivery of live bacteria. J. Biomed. Biotechnol. 2005(1), 44-56 (2005).
28. Haque T, Chen H, Ouyang W et al.: Investigation of a new microcapsule membrane combining alginate, chitosan, polyethylene glycol and p0ly-L-lysine for cell transplantation applications. Int. J. Artif. Organs 28(6), 631-637 (2005).
29. Prakash S, Bathena J: Live immobilised cells as new therapeutics. J. Drug Deliv. Sci. Technol. 18(1), 3-14 (2008).
30. Eikmeier H, Westmeier F, Rehm HJ: Morphological development of Aspelillus niger immobilized in Ca-alginate and κ-carrageenan. Appl. Microbiol. Biotechnol. 19, 53-57 (1984).
31. Hansen LT, Allan-Wojtas PM, Jin YL, Paulson AT: Survival of Ca-alginate microencapsulated Bifidobacterium spp. in milk and simulated gastrointestinal conditions. Food Microbiol. 19(1), 35-45 (2002).
32. Norton S, Lacroix C, Vuillemard JC: Effect of PH on the morphology of Lactobacillus helveticus in free cell batch and immobilized-cell continuous fermentation. Food Biotechnol. 7, 235-251 (1993).
33. Bartkowiak A, Hunkeler D: Alginate-oligochitosan microcapsules. II. Control of mechanical resistance and permeability of the membrane. Chem. Mater. 12(1), 206-212 (2000).
34. Awrey DE, Tse M, Hortelano G, Chang PL: Permeability of alginate microcapsules to secretory recombinant gene products. Biotechnol. Bioeng. 52(4), 472-484 (1996).
35. Strand BL, Gaserod O, Kulseng B, Espevik T, Skjak-Baek G: Alginate-polylysine-alginate microcapsules: effect of size reduction on capsule properties. J. Microencapsul. 19(5), 615-630 (2002).
36. Rehor A, Canaple L, Zhang Z, Hunkeler D: The compressive deformation of multicomponent microcapsules: influence of size, membrane thickness, and compression speed. J. Biomater. Sci. Polym. Ed. 12(2), 157-170 (2001).
37. Wang T, Lacfk I, Brissová M et al.: An encapsulation system for the immunoisolation of pancreatic islets. Nat. Biotechnol. 15(4), 358-362 (1997).
38. Tse M, Uludag H, Sefton MV, Chang PL: Secretion or recombinant proteins from hydroxyethyl methacrylate-methyl methacrylate capsules. Biotechnol. Bioeng. 51(3), 271-280 (1996).
39. Crooks CA, Douglas JA, Broughton RL, Sefton MV: Microencapsulation of mammalian cells in a HEMA-MMA copolymer: effects on capsule morphology and permeability. J. Biomed. Mater. Res. 24(9), 1241-1262 (2004).
40. Cai X, Lin Y, Ou G et al.: Ectopic osteogenesis and chondrogenesis of bone marrow stromal stem cells in alginate system. Cell Biol. Int. 31(8), 776-783 (2007).
41. Zilberman Y, Turgeman G, Pelled G et al.: Polymer-encapsulated engineered adult mesenchymal stem cells secrete exogenously regulated rhBMP-2, and induce osteogenic and angiogenic tissue formation. Polym. Adv. Technol. 13(10-12), 863-870 (2002).
42. Murua A, Portero A, Orive G, Hernández RM, Castro M, Pedraz JL: Cell microencapsulation technology: towards clinical application. J. Control. Release 132(2), 76-83 (2008).
43. Stolzing A, Scutt A: Age-related impairment of mesenchymal progenitor cell function. Aging Cell 5(3), 213-224 (2006).
44. Zhang H, Zhu SJ, Wang W, Wei YJ, Hu SS: Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis, and improves heart function. Gene Ther. 15(1), 40-48 (2008).
45. Kamihata H, Matsubara H, Nishiue T et al.: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104(9), 1046-1052 (2001).
46. Atoui R, Asenjo JF, Duong M, Chen G, Chiu RC, Shum-Tim D: Marrow stromal cells as universal donor cells for myocardial regenerative therapy: their unique immune tolerance. Ann. Thorac. Surg. 85(2), 571-579 (2008).
47. Maguire T, Novik E, Schloss R, Yarmush M: Alginate-PLL microencapsulation: effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol Bioeng. 93(3), 581-591 (2006).
48. Liu Z, Chang TMS: Effects of bone marrow cells on hepatocytes: when co-cultured or co-encapsulated together. Artif. Cells Blood Substit. Immobil. Biotechnol. 28(4), 365-374 (2000).
49. Liu Z, Chang TMS: Coencapsulation hepatocytes and bone marrow stem cells: in vitro conversion of ammonia and in vivo studies on the lowering of bilirubin in Gunn rats after transplantation. Int. J. Artif. Organs 26(6), 491-497 (2003).
50. Steinert A, Weber M, Dimmler A et al.: Chondrogenic differentiation of mesenchymal progenitor cells encapsulated in ultrahigh viscosity alginate. J. Orthop. Res. 21(6), 1090-1097 (2003).
51. Hwang YS, Cho J, Tay F et al.: The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials 30(4), 499-507 (2009).
52. Sakai S, Hashimoto I, Kawakami K: Production of cell-enclosing hollow-core agarose microcapsules via jetting in water-immiscible liquid paraffin and formation of embryoid body-like spherical tissues from mouse ES cells enclosed within these microcapsules. Biotechnol. Bioeng. 99(1), 235-243 (2008).
53. Dean SK, Yulyana Y, Williams G, Sidhu KS, Tuch BE: Differentiation of encapsulated embryonic stem cells after transplantation. Transplantation 82(9), 1175-84 (2006).
54. Orlic D, Hill J, Arai A: Stem cells for myocardial regeneration. Circ. Res. 91, 1092-1102 (2002).
55. Smits AM, Vliet P, Metz CH et al.: Human cardiornyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat. Protoc. 4(2), 232-243 (2009).
56. Taylor DA, Atkins BZ, Hungspreugs P et al.: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4(8), 929-933 (1998).
57. Ghostine S, Carrion C, Souza LC et al.: Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation. 106(Suppl. 1) 1131-1136 (2002).
58. Kolossov E, Bostani T, Roell W et al.: Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J. Exp. Med. 203(10), 2315-2327 (2006).
59. Kofidis T, Lebl DR, Swijnenburg RJ, Greeve JM, Klima U, Robbins RC: Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur. J. Cardiothorac. Surg. 29(1), 50-55 (2006).
60. Beltrami AP, Barlucchi L, Torella D et al.: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114(6), 763-776 (2003).
61. Chandy T, Mooradian DL, Rao GH: Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif. Organs 23(10), 894-903 (1999).
62. + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433(7026), 647-653 (2005).
63. Laflamme MA, Murry CE: Regenerating the heart. Nat. Biotechnol. 23(7), 845-856 (2005).
64. Xu M, Wani M, Dai YS et al.: Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation 110(17), 2658-2665 (2004).
65. Li X, Yu X, Lin Q et al.: Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J. Mol. Cell. Cardiol. 42(2), 295-303 (2007).
66. Toma C, Pittenger ME, Cahill KS, Byrne BJ, Kessler PD: Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105(1), 93-98 (2002).
67. Orlic D, Kajstura J, Chimenti S et al.: Bone marrow cells regenerate infarcted myocardium. Nature 410(6829), 701-705 (2001).
68. Fuchs S, Satler LF, Kornowski R et al.: Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J. Am. Coll. Cardiol. 41(10), 1721-1724 (2003).
69. Hamano K, Nishida M, Hirata K et al.: Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ. J. 65(9), 845-847 (2001).
70. Hendrikx M, Hensen K, Clijsters C et al.: Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 114(Suppl. 1), 1101-1107 (2006).
71. + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J. Thorac. Cardiovasc. Surg. 133(3), 717-725 (2007).
72. Amado LC, Saliaris AP, Schuleri KH et al.: Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl Acad. Sci. USA 102(32), 11474-11479 (2005).
73. Moelker AD, Bakas T, Wever KM et al.: Intracoronary delivery of umbilical cord blood derived unrestricted somatic cells is not suitable to improve IV function after myocardial infarction in swine. J. Mol. Cell. Cardiol. 42(4), 735-745 (2007).
74. Perin EC, Lopez J: Methods of stem cell delivery in cardiac diseases. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1), S110-S113 (2006).
75. Ishida M, Tomita S, Nakatani T et al.: Acute effects of direct cell implantation into the heart: a pressure-volume study to analyze cardiac function. J. Heart Lung Transplant. 23(7), 881-888 (2004).
76. Grossman PM, Han Z, Palasis M, Barry JJ, Lederman RJ: Incomplete retention after direct myocardial injection. Catheter Cardiovasc. Interv. 55(3), 392-397 (2002).
77. Qu Z, Balkir L, Deutekorn JC, Robbins PD, Pruchnic R, Huard J: Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 142(5), 1257-1267 (1998).
78. Hou D, Youssef EA, Brinton TJ et al.: Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112, 1150-1156 (2005).
79. Teng C, Luo J, Chin CR, Shum-Tim D: Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J. Thorac. Cardiovasc. Surg. 132(3), 628-632 (2006).
80. Kindi A, Chen GY, Asenjo JF et al.: Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy. Presented at: Canadian Cardiovascular Congress. Quebec City, PQ, Canada, 20-24 October 2007
81. Kindi A, Chen GY, Asenjo JF et al.: Cellular cardiomyoplasty: optimizing cellular dosage and retention by microencapsulation. Presented at: American Heart Association Scientific Sessions. Orlando, FL, USA, 4-7 November 2007.
82. Fu Y, Kedziorek D, Ouwerkerk R et al.: Multifunctional perfluorooctylbromide alginate microcapsules for monitoring of mesenchymal stem cell delivery using CT and MRI. Presented at: 12th Annual SCMR Scientific Sessions. Orlando, FL, USA, 29 January-1 February 2009.
83. Nygren JM, Jovinge S, Breitbach M et al.: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10(5), 494-501 (2004).
84. Gnecchi M, He H, Liang OD et al.: Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11(4), 367-368 (2005).
85. Suzuki K, Murtuza B, Beauchamp JR et al.: Role of interleukin-1β in acute inflammation and graft death after cell transplantation to the heart. Circulation 110(Suppl. 1), 219-224 (2004).
86. Yasuda T, Weisel RD, Kiani C, Mickle DA, Maganti M, Li RK: Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction. J. Thorac. Cardiovasc. Surg. 129(4), 904-911 (2005).
87. Bittira B, Shum-Tim D, Al-Khaldi A, Chiu RC: Mobilization and homing of bone marrow stromal cells in myocardial infarction. Eur. J. Cardiothorac. Surg. 24(3), 393-398 (2003).
88. Jiang W, Ma A, Wang T et al.: Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study. Pflugers Arch. 453(1), 43-52 (2006).
89. Saito T, Kuang JQ, Bittira B, Al-Khaldi A, Chiu RC: Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann. Thorac. Surg. 74(1), 19-24 (2002).
90. Ye L, Haider H, Guo C, Sim EK: Cell-based VEGF delivery prevents donor cell apoptosis after transplantation. Ann. Thorac. Surg. 83(3), 1233-1234 (2007).
91. Siti-Ismail N, Bishop AE, Polak JM, Mantalaris A: The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 29(29), 3946-3952 (2008).